ASCO GI 2022 Conference Coverage
ASCO GI 2022 Highlights on a Multicenter Phase II Study of Neoadjuvant Nivo+/-Relatlimab + CRT in Stage II/III EC/GEJC
By
ASCO GI 2022 Conference Coverage
FEATURING
Ronan Kelly
By
ASCO GI 2022 Conference Coverage
FEATURING
Ronan Kelly
Comments 0
Login to view comments.
Click here to Login
